StonvexLoading…
StonvexStonvexStonvexCore line items from BAC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $30.27B | $113.10B | $81.92B | $53.83B |
Operating Income | $10.40B | $37.70B | $25.26B | $15.80B |
Net Income | $8.58B | $30.51B | $22.98B | $14.51B |
EPS (Diluted) | $1.11 | $3.81 | $2.85 | $1.79 |
Total Assets | $3.50T | $3.41T | $3.40T | $3.44T |
Total Liabilities | $3.20T | $3.11T | $3.10T | $3.14T |
Cash & Equivalents | $242.48B | $231.84B | $246.51B | $266.01B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 7.13B | 7.21B | 7.33B | 7.44B |